Cystine accumulation and loss in normal, heterozygous, and cystinotic fibroblasts
- PMID: 6956872
- PMCID: PMC346688
- DOI: 10.1073/pnas.79.14.4442
Cystine accumulation and loss in normal, heterozygous, and cystinotic fibroblasts
Abstract
Cystinotic fibroblasts contain approximately 100 times more cystine than do normal control fibroblasts. When cystinotic fibroblasts were placed in the presence of 30 mM cysteine-glutathione mixed disulfide (CSSG) for 24 hr, their cystine content increased about 3-fold. Similar treatment of normal fibroblasts and fibroblasts from patients heterozygous for cystinosis resulted in a 6- to 7-fold increase in cystine content. In all three cell types, the intracellular free cystine is located within lysosomes. When placed in cystine-free medium after 24 hr in CSSG-containing medium, the normal and heterozygous fibroblasts rapidly lost their lysosomal cystine (t 1/2 = 20 min), but the cystine content of the cystinotic cells remained stable for over 90 min. In contrast to the findings in intact fibroblasts, cystine loss could not be demonstrated from isolated, cystine-loaded lysosomes from any of the three cell types.
Similar articles
-
Lysosomal cystine storage in cystinosis and mucolipidosis type II.Pediatr Res. 1985 Nov;19(11):1170-4. doi: 10.1203/00006450-198511000-00011. Pediatr Res. 1985. PMID: 4069825
-
Altered status of glutathione and its metabolites in cystinotic cells.Nephrol Dial Transplant. 2005 Sep;20(9):1828-32. doi: 10.1093/ndt/gfh932. Epub 2005 Jun 14. Nephrol Dial Transplant. 2005. PMID: 15956064
-
Utilization of mercaptoethylgluconamide for depleting human cystinotic fibroblasts of their accumulated lysosomal cystine.Pediatr Res. 1989 Jul;26(1):73-6. doi: 10.1203/00006450-198907000-00020. Pediatr Res. 1989. PMID: 2771512
-
A review of the role of enhanced apoptosis in the pathophysiology of cystinosis.Mol Genet Metab. 2007 Dec;92(4):292-8. doi: 10.1016/j.ymgme.2007.07.008. Epub 2007 Aug 28. Mol Genet Metab. 2007. PMID: 17728168 Review.
-
Cystine exodus from lysosomes: cystinosis.Methods Enzymol. 1989;174:154-62. doi: 10.1016/0076-6879(89)74016-7. Methods Enzymol. 1989. PMID: 2698986 Review. No abstract available.
Cited by
-
Genetic basis of cystinosis in Tunisian patients: Identification of novel mutation in CTNS gene.Meta Gene. 2015 Jul 25;5:144-9. doi: 10.1016/j.mgene.2015.07.003. eCollection 2015 Sep. Meta Gene. 2015. PMID: 26266097 Free PMC article.
-
Physiological Media in Studies of Cell Metabolism.Mol Biol. 2022;56(5):629-637. doi: 10.1134/S0026893322050077. Epub 2022 Oct 5. Mol Biol. 2022. PMID: 36217338 Free PMC article.
-
LAAT-1 is the lysosomal lysine/arginine transporter that maintains amino acid homeostasis.Science. 2012 Jul 20;337(6092):351-4. doi: 10.1126/science.1220281. Science. 2012. PMID: 22822152 Free PMC article.
-
Cystinosin, the protein defective in cystinosis, is a H(+)-driven lysosomal cystine transporter.EMBO J. 2001 Nov 1;20(21):5940-9. doi: 10.1093/emboj/20.21.5940. EMBO J. 2001. PMID: 11689434 Free PMC article.
-
CTNS mRNA molecular analysis revealed a novel mutation in a child with infantile nephropathic cystinosis: a case report.BMC Nephrol. 2019 Oct 31;20(1):400. doi: 10.1186/s12882-019-1589-2. BMC Nephrol. 2019. PMID: 31672123 Free PMC article.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
